The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...

For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...

This study protocol outlines a 12-week randomized trial testing whether a MIND diet intervention is feasible, acceptable, and ...

Carrick Therapeutics Inc., an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced positive results from the Phase 2 SUMIT-BC clinical ...

First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation ...

Objective To assess the feasibility of conducting a cluster randomised controlled trial comparing the effects of Advanced ...

Atlantic City, a place of historic mayoral misdeeds, multi-millionaire overreach and chronic unwanted attention, has managed ...

FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL Marks the start of the second Phase IIa trial to evaluate first-in-class monoclonal antibody CIT-013 this year, following the ...

Essilorluxottica (OTC) ($ESLOY) announced an update on their ongoing clinical study. Essilorluxottica is currently conducting a clinical study ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...

Researchers found a chasm between the health reasons for which the public seeks out cannabis and what gold-standard science ...